Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

2.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

3.

The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.

March J, Silva S, Vitiello B; TADS Team.

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1393-403.

PMID:
17135984
4.

Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study.

Kratochvil CJ, May DE, Silva SG, Madaan V, Puumala SE, Curry JF, Walkup J, Kepley H, Vitiello B, March JS.

J Child Adolesc Psychopharmacol. 2009 Oct;19(5):519-27. doi: 10.1089/cap.2008.0143.

5.

A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults.

Skapinakis P, Caldwell D, Hollingworth W, Bryden P, Fineberg N, Salkovskis P, Welton N, Baxter H, Kessler D, Churchill R, Lewis G.

Health Technol Assess. 2016 Jun;20(43):1-392. doi: 10.3310/hta20430. Review.

6.

Treatment for Adolescents with Depression Study (TADS): safety results.

Emslie G, Kratochvil C, Vitiello B, Silva S, Mayes T, McNulty S, Weller E, Waslick B, Casat C, Walkup J, Pathak S, Rohde P, Posner K, March J; Columbia Suicidality Classification Group; TADS Team.

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1440-55.

7.
8.

Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.

Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, Sherlock S, Turner N, Button K, Odondi L, Metcalfe C, Owen-Smith A, Campbell J, Garland A, Hollinghurst S, Jerrom B, Kessler D, Kuyken W, Morrison J, Turner K, Williams C, Peters T, Lewis G.

Health Technol Assess. 2014 May;18(31):1-167, vii-viii. doi: 10.3310/hta18310.

9.

Acute time to response in the Treatment for Adolescents with Depression Study (TADS).

Kratochvil C, Emslie G, Silva S, McNulty S, Walkup J, Curry J, Reinecke M, Vitiello B, Rohde P, Feeny N, Casat C, Pathak S, Weller E, May D, Mayes T, Robins M, March J; TADS Team.

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1412-8.

PMID:
17135986
10.

Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.

Cox GR, Callahan P, Churchill R, Hunot V, Merry SN, Parker AG, Hetrick SE.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD008324. doi: 10.1002/14651858.CD008324.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;11:CD008324.

PMID:
23152255
11.

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.

March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J.

Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. Erratum in: Arch Gen Psychiatry. 2008 Jan;65(1):101.

PMID:
17909125
12.

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team.

JAMA. 2004 Aug 18;292(7):807-20.

PMID:
15315995
13.

Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial.

Goodyer I, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

BMJ. 2007 Jul 21;335(7611):142. Epub 2007 Jun 7.

14.

Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial.

Goodyer IM, Reynolds S, Barrett B, Byford S, Dubicka B, Hill J, Holland F, Kelvin R, Midgley N, Roberts C, Senior R, Target M, Widmer B, Wilkinson P, Fonagy P.

Health Technol Assess. 2017 Mar;21(12):1-94. doi: 10.3310/hta21120.

15.

Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.

Vitiello B, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller MB, Birmaher B, Ryan ND, Kennard B, Mayes TL, DeBar L, Lynch F, Dickerson J, Strober M, Suddath R, McCracken JT, Spirito A, Onorato M, Zelazny J, Porta G, Iyengar S, Brent DA.

J Clin Psychiatry. 2011 Mar;72(3):388-96. doi: 10.4088/JCP.09m05885blu.

16.

Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).

Kennard B, Silva S, Vitiello B, Curry J, Kratochvil C, Simons A, Hughes J, Feeny N, Weller E, Sweeney M, Reinecke M, Pathak S, Ginsburg G, Emslie G, March J; TADS Team.

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1404-11.

PMID:
17135985
17.

Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy.

Rohde P, Silva SG, Tonev ST, Kennard BD, Vitiello B, Kratochvil CJ, Reinecke MA, Curry JF, Simons AD, March JS.

Arch Gen Psychiatry. 2008 Apr;65(4):447-55. doi: 10.1001/archpsyc.65.4.447.

18.

24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).

Piacentini J, Bennett S, Compton SN, Kendall PC, Birmaher B, Albano AM, March J, Sherrill J, Sakolsky D, Ginsburg G, Rynn M, Bergman RL, Gosch E, Waslick B, Iyengar S, McCracken J, Walkup J.

J Am Acad Child Adolesc Psychiatry. 2014 Mar;53(3):297-310. doi: 10.1016/j.jaac.2013.11.010. Epub 2013 Nov 28.

19.

Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.

Cox GR, Callahan P, Churchill R, Hunot V, Merry SN, Parker AG, Hetrick SE.

Cochrane Database Syst Rev. 2014 Nov 30;(11):CD008324. doi: 10.1002/14651858.CD008324.pub3. Review.

PMID:
25433518
20.

[Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].

Hjalmarsson L, Corcos M, Jeammet P.

Encephale. 2005 May-Jun;31(3):309-16. French.

PMID:
16142045

Supplemental Content

Support Center